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etiology may allow physicians to ensure better care for patients, in particular for
those suffering from ventricular arrythmias. However, a specific diagnosis is not
often searched for. The objective of this study is to assess the paraclinical evalua-
tion carried out for patients suffering from NICM in a tertiary care center. 
Methods Each patient suffering from a NICM and referred to Bordeaux’s Uni-
versity hospital for ventricular tachycardia ablation or implantable cardioverter
defibrillator implantation between 2007 and 2014 were include. Data concerning
demographic characteristics, medical tests and outcome were collected. We tried
to assess the usefulness of additionnal tests for the diagnosis of NICM. 
Results We did a monocentric observationnal descriptive study about
135 adult patients. Every patient had a TTE and a CA, 46.7% of them had a MRI-
scan, 34.8% had a CT-scan, 14.8% had a genetic testing, 1.5% had a PET-scan,
and 0.7% had a heart biopsy. Performing additionnal tests was useful in 38% of
our patients: it changed the diagnosis in 10% of cases and allowed to make a spe-
cific diagnosis in 28% of cases. Over the study period, we observed a significant
increase of the number of MRI-scans and CT-scans performed, evidence of a
change of practices. However 24% of overall patients only had TTE and CA with
no additional tests performed and were diagnosed a NICM by default.
Conclusion Despite a change in practices over the past years, not all
patients suffering from NICM have additional investigations. Yet, these tests
are often valuable, and the knowledge of a specific etiology can lead to a
better patient care and an early family screening.
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Rationale Cardiogenic shock (CS) at the acute stage of MI remains a major
concern. Information on its incidence over the past 20 years is discrepant, and little
is known of the evolution of long-term mortality over the years.
Methods and results We analysed the incidence and one-year mortality of
CS in 4 nationwide French survey carried out 5 years apart from 1995 to 2010.
Consecutive STEMI and NSTEMI patients (≤48 hours from onset) were
recruited over one-month periods. Among 10610 patients included in the 4
surveys, 614 (5.8%) had CS. Incidence of CS decreased (6.9% in 1995; 4.0%
in 2010, p<0.001), both for STEMI and NSTEMI. Pts with CS were older than
those without (74±12 vs 66±14y); mean age of CS pts remained unchanged.
In CS pts, use of PCI increased from 20% to 73%, and in STEMI patients with
CS, reperfusion therapy increased from 40% to 72%. Thirty-day mortality
(56.2% vs 4.3%) and one-year mortality (66.6% vs 10.3%) were considerably
higher in CS pts. Over the 15-year period, one-year mortality decreased for
both pts with (75% to 51%, P<0.001) and without CS (15% to 7%, P<0.001).
By Cox multivariate analysis in the whole population, both time period and
presence of CS were independent predictors of one-year mortality. In CS pts,
age, diabetes, higher BMI and type of MI (STEMI), were independent cor-
relates of increased one-year death, while time period was associated with
reduced mortality (HR:2010 vs 1995=0.57; 95% CI: 0.40-0.83, along with
early use of PCI and medications at the acute stage.
Conclusion In these 4 nationwide surveys conducted 15 years apart, the
incidence of CS decreased and one-year mortality of CS patients significantly
decreased. Although improved survival was associated with a broader use of
PCI and appropriate medications at the acute stage, the fact that time period
remained an independent predictor of improved outcomes suggests improved
overall process of care. 
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Introduction The prognostic value of atrial fibrillation (AF) in heart failure
with preserved ejection fraction (HFPEF) remains controversial. The objective of
the KaRen (Karolinska-Rennes) sub-study was to explore this question.
Methods KaRen was a prospective, multicenter, international, observa-
tional study intended to characterize HFPEF; 538 patients presenting acute
decompensated cardiac failure with a left ventricular ejection fraction >45%
were included. A physical exam as well as an EKG and an echocardiogram
were scheduled 4-8 week following the index hospitalization, and the patients
were evaluated at 6-month intervals. 
We compared clinical and echocardiographic characteristics of patients in
sinus rhythm vs. patients with documented AF upon their 4-8-week visit. The
primary study endpoint was death from any cause or first hospitalization for
decompensated heart failure (HF).
Results A total of 413 patients (244 patients in sinus rhythm and 134 in AF;
32% of overall population) were analyzed, with a mean follow-up period of 28
months. The patients were primarily elderly individuals (76.2 years), with a slight
female predominance and a high prevalence of comorbidities. The baseline echo-
cardiographic characteristics and the natriuretic peptide levels were indicative of a
more severe heart condition among the patients with AF. However, the patients
with AF exhibited a similar survival-free interval compared with the patients in
sinus rhythm (p=0.89). Similar survival was observed according to patients’ heart
rhythm on enrolment (decompensated HF) or according to patients’ cardiac his-
tory. Heart rate (stratified in tertiles), neurohormonal blockade or anticoagulant
treatments at the 4-8-week visit were not independent predictors of outcome. 
Conclusion In this HFPEF population with a high prevalence of non-car-
diovascular comorbidities, the presence of AF was not associated with a
poorer prognosis despite impaired clinical and echocardiographic features. 
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Background Sleep-disordered breathing (SDB) is commonly in chronic
heart failure (CHF) patients. 
Exercise training (ET) improves exercise tolerance and reduces cardiac decom-
pensations in CHF population. Otherwise, ventilation therapy (VT) improves
prognosis and exercise capacity in CHF patients with SDB. However, the effect of
the combination therapy: ET and VT is still unexplored. The aim of our study is
to evaluate the effects on hemodynamic status (cardiac decompensations) of ET
and VT in stable CHF patients referred to cardiac rehabilitation (CR).
Methods We included 118 stable CHF patients with an apnea-hypopnea
index (AHI) >15/h diagnosed by polygraphy. They were randomized into
exercise training (ET group n=58) or combined exercise and ventilation
(ET+VT group n=60). The follow up period was the 8 weeks during which 20
exercise training sessions were scheduled. Severe episodes of cardiac decom-
pensations were recorded.
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